1. Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan
- Author
-
Chien-Hung Chen, Cheng-Si Wang, Chao-Wei Hsu, Yi-Le Wu, Guan-Yu Lin, Po-Hsin Peng, Chia-Yun Ko, and Pei-Jer Chen
- Subjects
0301 basic medicine ,Anti hdv ,viruses ,Taiwan ,Enzyme-Linked Immunosorbent Assay ,Biology ,medicine.disease_cause ,Sensitivity and Specificity ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Sensitivity ,Limit of Detection ,Virology ,HDV ,medicine ,Humans ,lcsh:RC109-216 ,Hepatitis Antibodies ,chemistry.chemical_classification ,Hepatitis B virus ,Plasma samples ,Kit evaluation ,Research ,virus diseases ,biochemical phenomena, metabolism, and nutrition ,Hepatitis D ,030104 developmental biology ,Infectious Diseases ,Enzyme ,chemistry ,biology.protein ,Specificity ,030211 gastroenterology & hepatology ,ELISA ,Hepatitis D virus ,Reagent Kits, Diagnostic ,Antibody ,Hepatitis Delta Virus - Abstract
Background Hepatitis D virus (HDV) infection is a major global health issue around the world. There are approximately 15–20 million individuals infected with HDV worldwide. HDV infection usually causes increased mortality compared with infection with hepatitis B virus (HBV) alone. However, testing for the detection of HDV is not widely available in Taiwan. Therefore, the General Biologicals Corporation (GB) HDV Ab kit was developed for detecting anti-HDV antibodies. Methods A total of 913 serum and 462 EDTA-treated plasma samples were obtained from HBsAg-positive individuals in three hospitals in Taiwan from June 2014 to November 2017. We used three commercially available ELISA kits, DiaPro HDV Ab, DiaSorin ETI-AB-DELTAK-2 and GB HDV Ab, which were utilized strictly according to the instructions of the manufacturers. Results A comparative study of the results from the GB HDV Ab kit and the other commercial ELISA kits (DiaPro and DiaSorin) was performed to determine their efficacy for anti-HDV detection. The results indicated that the sensitivity of the GB HDV Ab kit for serum and EDTA samples was 100% compared to that of the DiaPro and DiaSorin kits, whereas the specificity for serum and EDTA samples was 99.3 and 98.1%, respectively. In addition, the overall agreement of the results of the GB HDV Ab kit for the serum and EDTA samples was 99.3 and 98.3%, respectively. It is worth noting that the performance of the GB HDV Ab kit was not affected by interference from triglyceride, bilirubin, hemoglobin, or human anti-mouse antibody. The limit of detection of the GB HDV Ab kit is approximately 100-fold lower than that of the other two commercial kits. Conclusions The GB HDV Ab kit, which presented equivalent sensitivity and specificity compared to both certified anti-HDV kits, would be a suitable kit for HDV diagnosis in Taiwan.
- Published
- 2020